详情页 - 首都医科大学宣武医院知识库

当前位置：首页 > 详情页

Stem Cell Treatment for Alzheimer's Disease

文献详情

资源类型：

收录情况： ◇ SCIE

作者：

机构： [1]Kansai Med Univ, Dept Stem Cell Disorders, Hirakata, Osaka 5731010, Japan; [2]Capital Med Univ, Dept Cardiac Surg, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Beijing 100029, Peoples R China; [3]Kansai Med Univ, Dept Stem Cell Disorders, 2-5-1 Shinmachi, Hirakata, Osaka 5731010, Japan

出处：

DOI：

ISSN：

关键词： Alzheimer's disease stem cell therapy oxidative stress neurodegeneration

摘要：

Alzheimer's disease (AD) is a progressive and neurodegenerative disorder that induces dementia in older people. It was first reported in 1907 by Alois Alzheimer, who characterized the disease as causing memory loss and cognitive impairment. Pathologic characteristics of AD are beta-amyloid plaques, neurofibrillary tangles and neurodegeneration. Current therapies only target the relief of symptoms using various drugs, and do not cure the disease. Recently, stem cell therapy has been shown to be a potential approach to various diseases, including neurodegenerative disorders, and in this review, we focus on stem cell therapies for AD.

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2013]版：

大类 | 3 区化学

小类 | 3 区化学综合

最新[2023]版：

大类 | 2 区生物学

小类 | 3 区生化与分子生物学 3 区化学：综合

JCR分区：

出版当年[2012]版：

Q2 CHEMISTRY, MULTIDISCIPLINARY

最新[2023]版：

Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q2 CHEMISTRY, MULTIDISCIPLINARY

影响因子： 4.9 最新[2023版] 5.6 最新五年平均 2.464 出版当年[2012版] 2.732 出版当年五年平均 2.598 出版前一年[2011版] 2.339 出版后一年[2013版]

第一作者：

第一作者机构： [1]Kansai Med Univ, Dept Stem Cell Disorders, Hirakata, Osaka 5731010, Japan;

通讯作者：

通讯机构： [1]Kansai Med Univ, Dept Stem Cell Disorders, Hirakata, Osaka 5731010, Japan; [3]Kansai Med Univ, Dept Stem Cell Disorders, 2-5-1 Shinmachi, Hirakata, Osaka 5731010, Japan

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Lipid metabolism and oxidative stress in patients with Alzheimer's disease and amnestic mild cognitive impairment [2]Lipid metabolism and oxidative stress in patients with Alzheimer's disease and amnestic mild cognitive impairment [3]Effects of cysteamine on MPTP-induced dopaminergic neurodegeneration in mice [4]Tetrahydroxy stilbene glycoside ameliorates Alzheimer's disease in APP/PS1 mice via glutathione peroxidase related ferroptosis. [5]Bone marrow stem cell therapy for stroke [6]氧化应激与糖尿病 [7]DJ-1 interacts with RACK1 and protects neurons from oxidative-stress-induced apoptosis [8]氧化应激与阿尔茨海默病 [9]Sulforaphane Inhibits the Generation of Amyloid-beta Oligomer and Promotes Spatial Learning and Memory in Alzheimer's Disease (PS1V97L) Transgenic Mice [10]Analyses of Clinical Features and Investigations on Potential Mechanisms in Patients with Alzheimer's Disease and Olfactory Dysfunction